Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TPMT | P51580 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748562 | 0.83 | IDO1 (0.49) | IDO1TPMTALDH1A1HPGDKDM4E | |
| SCHEMBL7715 | 0.83 | IDO1 (0.49) | IDO1TPMTALDH1A1HPGDKDM4E | |
| SCHEMBL21592065 | 0.82 | PTPRC (0.40) | SMN1; SMN2TPMTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL1748053 | 0.81 | MKNK1 (0.46) | IDO1TPMTCA1CA2 | |
| SCHEMBL28879905 | 0.80 | TTR (0.39) | SMN1; SMN2TPMTKMT2AALDH1A1CYP3A4 | |
| SCHEMBL20776932 | 0.78 | IDO1 (0.33) | IDO1KMT2A | |
| SCHEMBL3341120 | 0.78 | ALDH1A1 (0.55) | SMN1; SMN2KMT2AALDH1A1CYP3A4HPGD | |
| SCHEMBL2351916 | 0.78 | KDM4E (0.49) | SMN1; SMN2ALDH1A1HPGDCA1CA2 | |
| SCHEMBL22226016 | 0.78 | MAP2K1 (0.42) | SMN1; SMN2IDO1KMT2AHPGDTSHR | |
| SCHEMBL96218 | 0.77 | KMT2A (0.51) | SMN1; SMN2KMT2AALDH1A1CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7524864-B2 | Methods of treating sleep disorders | HYPNION, INC. (US) | 2009-04-28 | — | — | US | disclosed |
| US-7524864-B2 | Methods of treating sleep disorders | HYPNION, INC. (US) | 2009-04-28 | — | — | US | disclosed |
| US-7482460-B2 | Doxepin analogs and methods of use thereof | HYPNION, INC. (US) | 2009-01-27 | — | — | US | disclosed |
| US-7482460-B2 | Doxepin analogs and methods of use thereof | HYPNION, INC. (US) | 2009-01-27 | — | — | US | disclosed |
| US-7411069-B2 | Doxepin analogs and methods of use thereof | HYPNION, INC. (US) | 2008-08-12 | — | — | US | disclosed |
| US-7411069-B2 | Doxepin analogs and methods of use thereof | HYPNION, INC. (US) | 2008-08-12 | — | — | US | disclosed |
| US-7384749-B2 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| US-7381533-B2 | Electrodes linked via oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7381525-B1 | AC/DC voltage apparatus for detection of nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7355042-B2 | Treatment of CNS disorders using CNS target modulators | HYPNION, INC. (US) | 2008-04-08 | — | — | US | disclosed |
| US-6479240-B1 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. | 2002-11-12 | — | — | US | disclosed |
| US-6232062-B1 | HYBRIDIZATION | CLINICAL MICRO SENSORS, INC. | 2001-05-15 | — | — | US | disclosed |
| US-6221583-B1 | USE OF NUCLEIC ACIDS CONTAINING ELECTRON TRANSFER MOIETIES TO BE USED AS NUCLEIC ACID PROBES; PROBE NUCLEIC ACID IS COVALENTLY ATTACHED TO AN ELECTRODE VIA A CONDUCTIVE OLIGOMER | CLINICAL MICRO SENSORS, INC. | 2001-04-24 | — | — | US | disclosed |
| US-6096273-A | SITE-SELECTIVE MODIFICATION OF NUCLEIC ACIDS WITH ELECTRON TRANSFER MOIETIES AND ELECTRODES, FOR GENE PROBES, MEDICAL DIAGNOSIS, TISSUE COMPATIBILITY EVALUATIONS BEFORE TRANSPLANTATION, FORENSICS | CLINICAL MICRO SENSORS (US) | 2000-08-01 | — | — | US | disclosed |
| US-6090933-A | ATTACHING THE SULFUR OF A CONDUCTIVE OLIGOMER HAVING A FIRST SUBUNIT OF A SULFUR ATOM PROTECTED BY ETHYL PYRIDINE OR TRIMETHYLSILYL ETHYL, TO THE GOLD ELECTRODE; NUCLEIC ACIDS COVALENTLY COUPLED TO ELECTRODES VIA CONDUCTIVE OLIGOMERS | CLINICAL MICRO SENSORS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| US-6063573-A | SINGLE-STRANDED PROBE FOR SCREENING TARGET NUCLEOTIDE SEQUENCES | CLINICAL MICRO SENSORS, INC. (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0939762-A2 | ELECTRODES LINKED VIA CONDUCTIVE OLIGOMERS TO NUCLEIC ACIDS | Clinical Micro Sensors (US) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998020162-A2 | ELECTRODES LINKED VIA CONDUCTIVE OLIGOMERS TO NUCLEIC ACIDS | CLINICAL MICRO SENSORS (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5374628-A | Aryl and heteroaryl(phosphinylmethyl)phosphonate squalene synthetase inhibitors and method | E. R. SQUIBB & SONS, INC. (US) | 1994-12-20 | — | — | US | disclosed |
| US-5278153-A | Hypocholesterolemic or hypolipemic | E. R. SQUIBB & SONS, INC. (US) | 1994-01-11 | — | — | US | disclosed |